AtriCure to Participate in the 2026 Bank of America Securities Health Care Conference
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 2026 Bank of America Securities Health Care Conference.
AtriCure’s management is scheduled to participate in a fireside chat on Tuesday, May 12, 2026, at 10:00 a.m. Pacific Daylight Time. Interested parties may access a live audio webcast by visiting the “Investors” section of the company’s website at https://ir.atricure.com.
About AtriCure
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 59 million people worldwide. Surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® and cryoXT® probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac, thoracic and amputation procedures. For more information, visit AtriCure.com or follow us on X @AtriCure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260428134254/en/
Angie Wirick
AtriCure, Inc.
Chief Financial Officer
(513) 755-5334
[email protected]
Marissa Bych
Gilmartin Group
Investor Relations
[email protected]
KEYWORDS: Ohio United States North America
INDUSTRY KEYWORDS: Biotechnology Health Other Health Surgery Other Science Research Medical Devices General Health Hospitals Health Technology Science Clinical Trials Cardiology Medical Supplies
MEDIA:
| Logo |
 |